Evidence map›Paper›PMID 23884466›Full record

ArticleScience translational medicine2013

TGFβ receptor mutations impose a strong predisposition for human allergic disease.

Pamela A Frischmeyer-Guerrerio, Anthony L Guerrerio, Gretchen Oswald, Kristin Chichester, Loretha Myers, Marc K Halushka, Maria Oliva-Hemker, Robert A Wood, Harry C Dietz

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Science translational medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02504853 (Natural History and Genetics of Food Allergy and Related Conditions), which is not on this map. Cited by 113 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
113citing papers in PubMed, 1 pooled it
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02504853 recruitingnot on this mapstarted 2015, after this paper: background citation

Natural History and Genetics of Food Allergy and Related Conditions

TypeobservationalSponsorNational Institute of Allergy and Infectious Diseases (NIAID)Ran2015 to 2027Enrolled1,800ConditionsFood Allergy, Loeys-Dietz Syndrome, Atopic Dermatitis, Eosinophilic Esophagitis
3 · Its place in the literature

Who cites it

113 citing papers in PubMed, 1 synthesis or guideline pooled it, 217 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Immune functions of the esophagus.The Journal of allergy and clinical immunology · 2026
    Review
  7. Review
  8. Article
  9. The oesophagus as an immune organ.Nature reviews. Gastroenterology & hepatology · 2025
    Review
  10. Article
  11. Review
  12. Article
  13. The genetics of hyper IgE syndromes.Frontiers in immunology · 2025
    Review
  14. Understanding and Managing Hyper IgE Syndromes.ImmunoTargets and therapy · 2025
    Review
  15. Review
  16. TThe Journal of allergy and clinical immunology · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Article

53 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Pamela A Frischmeyer-GuerrerioDepartment of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Anthony L Guerrerio
Gretchen Oswald
Kristin Chichester
Loretha Myers
Marc K Halushka
Maria Oliva-Hemker
Robert A Wood
Harry C Dietz
Johns Hopkins Medicine · USJohns Hopkins University · US

Funding

National Gnotobiotic Rodent Resource CenterP40OD010995 · OD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Ryan B Sartor · 2012 to 2026
$9.7M
BASIC SCIENCE RESEARCH IN DIGESTIVE DISEASEST32DK007632 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI DONOWITZ, MARK · 1989 to 2018
$5.4M
MOLECULAR BIOLOGY OF THE MARFAN SYNDROMER01AR041135 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI DIETZ, HARRY C., III · 1992 to 2016
$5.2M
Investigation of the Role of TGF Beta in TH2-Mediated DiseaseK23AI091869 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GUERRERIO, PAMELA ANN · 2011 to 2014
$537k
Howard Hughes Medical InstituteNIAID NIH HHS K23 AI091869NIAID NIH HHS K23AI091869NIAID NIH HHS L40 AI080219NIAMS NIH HHS R01 AR041135NIDDK NIH HHS T32 DK007632NIDDK NIH HHS T32 DK07632
6 · The paper itself

Abstract

Transforming growth factor-β (TGFβ) is a multifunctional cytokine that plays diverse roles in physiologic processes as well as human disease, including cancer, heart disease, and fibrotic disorders. In the immune system, TGFβ regulates regulatory T cell (Treg) maturation and immune homeostasis. Although genetic manipulation of the TGFβ pathway modulates immune tolerance in mouse models, the contribution of this pathway to human allergic phenotypes is not well understood. We demonstrate that patients with Loeys-Dietz syndrome (LDS), an autosomal dominant disorder caused by mutations in the genes encoding receptor subunits for TGFβ, TGFBR1 and TGFBR2, are strongly predisposed to develop allergic disease, including asthma, food allergy, eczema, allergic rhinitis, and eosinophilic gastrointestinal disease. LDS patients exhibited elevated immunoglobulin E levels, eosinophil counts, and T helper 2 (TH2) cytokines in their plasma. They had an increased frequency of CD4(+) T cells that expressed both Foxp3 and interleukin-13, but retained the ability to suppress effector T cell proliferation. TH2 cytokine-producing cells accumulated in cultures of naïve CD4(+) T cells from LDS subjects, but not controls, after stimulation with TGFβ, suggesting that LDS mutations support TH2 skewing in naïve lymphocytes in a cell-autonomous manner. The monogenic nature of LDS demonstrates that altered TGFβ signaling can predispose to allergic phenotypes in humans and underscores a prominent role for TGFβ in directing immune responses to antigens present in the environment and foods. This paradigm may be relevant to nonsyndromic presentations of allergic disease and highlights the potential therapeutic benefit of strategies that inhibit TGFβ signaling.

Indexed as

CD4-Positive T-LymphocytesCytokinesFlow CytometryForkhead Transcription FactorsGenetic Predisposition to DiseaseHumansHypersensitivityImmunoglobulin EInterleukin-13Loeys-Dietz SyndromeMutationProtein Serine-Threonine KinasesReceptors, Transforming Growth Factor betaReceptor, Transforming Growth Factor-beta Type IIT-Lymphocytes, RegulatoryCytokinesForkhead Transcription FactorsFOXP3 protein, humanImmunoglobulin EInterleukin-13Protein Serine-Threonine KinasesReceptors, Transforming Growth Factor betaReceptor, Transforming Growth Factor-beta Type II

Identifiers

PMID23884466
PMCPMC3905327
OpenAlexW2076245289

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.